Navigation Links
QLT restructures Visudyne(R) agreement
Date:10/19/2009

directly influence Visudyne sales in the U.S. by establishing a small focused sales force centered on retinal specialists."

As part of the restructure, QLT and Novartis have released each other from all open claims the parties may have against each other, including any in connection with QLT's litigation with Massachusetts Eye and Ear Infirmary and QLT's litigation with General Hospital Corporation (doing business as Massachusetts General Hospital).

About Visudyne

Visudyne therapy is a two-step procedure involving the intravenous administration of the drug into the patient's arm. A non-thermal laser light is then shone into the patient's eye to activate the drug. This produces a reaction that closes the abnormal leaky vessels, resulting in a stabilization of the corresponding vision loss.

Visudyne is approved worldwide for the treatment of a form of wet AMD, the leading cause of legal blindness in people over the age of 55, and has been used in more than two million treatments worldwide. Visudyne is commercially available in more than 80 countries for the treatment of predominantly classic subfoveal CNV. In addition, over 60 countries have approved Visudyne to treat other macular neovascular conditions such as minimally classic and occult with no classic AMD lesions, pathological myopia and presumed ocular histoplasmosis.

About QLT

QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative ocular therapies. We utilize two unique technology platforms, photodynamic therapy (used with the Visudyne product) and punctal plugs, which are currently under development for future product opportunities. For more information, visit our website at www.qltinc.com.

Visudyne is a registered trademark of Novartis AG.

QLT Inc. is listed on The NASDAQ Stock Market under the trading symbol "QLTI
'/>"/>

SOURCE QLT Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Misonix Restructures and Expands Sales Organization in Europe
2. Medicsight PLC Restructures Management Team
3. Haemacure Restructures - Seeks Financing or Sale of the Company
4. eFoodSafety.com Restructures purEffect(TM) Marketing Agreement with CK41
5. NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure
6. VaxGen Restructures Following Termination of Proposed Merger
7. Pharmos Restructures Operations in Israel
8. QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
9. QLT announces positive results from the evaluation of Visudyne(R) combination therapy
10. QLT announces Visudyne(R) sales for fourth quarter and fiscal year 2008
11. QLT announces first quarter 2008 Visudyne(R) sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Dec. 18, 2014 (HealthDay News) -- Traveling through the ... measles virus to three others within a four-hour time ... a new report shows. "The exposures in this ... rather than an international terminal, highlighting the fact that ... Jared Vega, an infectious disease specialist at the U.S. ...
(Date:12/19/2014)... HealthDay Reporter THURSDAY, Dec. 18, 2014 ... for at least 20 seconds you may be at risk ... one leg may indicate that small strokes or tiny bleeds ... strokes is high, the investigators reported online Dec. 18 in ... standing on one leg, as well as problems walking, should ...
(Date:12/17/2014)... 2014 Dr. Myo Nwe is the co-author ... of the Future” and co-founder of the Ace Medical Weight ... Nwe takes a broad look at the industry of weight ... scientific scrutiny. On film and in television shows, however, she ... the social aspects and played for basic laughs, which she ...
(Date:12/17/2014)... RI (PRWEB) December 17, 2014 ... recognize private practices that have made outstanding and ... in support and progression of private practice physical ... American Physical Therapy Association. , On behalf of ... OCS, owner and CEO of Performance accepted the ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 A group of ... for Longevity, today, in reaction to a recent statement by ... of brain training and derogated the efficacy of all brain ... agreed with the parts of the center’s statement critical of ... the center had also overstated its case, in a document ...
Breaking Medicine News(10 mins):Health News:Arriving Now at Gate 42: Measles 2Health News:Arriving Now at Gate 42: Measles 3Health News:Can You Balance on One Leg? You May Have Lower Stroke Risk 2Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4
... WASHINGTON, Sept. 16 The Amputee Coalition of America and ... Tom Harkin and Olympia J. Snowe and Representatives Robert E. ... joint organizations, 2009 Legislative Appreciation Awards. , , ... http://www.prnewswire.com/mnr/aopa/40117/ , , (Photo: ...
... , , Prostate ... , DENVER, Sept. 16 This September, the Prostate ... take lifesaving measures. In just 10 minutes, the same amount ... screened for prostate cancer, the second leading cause of death among ...
... , , , NORWALK, ... theft protection services, today announced the availability of new features in its ... damaging types of identity theft: medical identity theft. , , ... if personal health records containing inaccurate information are used by health care ...
... WASHINGTON, Sept. 16 While research shows many American children become ... is reversing the trend by motivating them to be more physically ... To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/ccna/39748/ ... launched in 2005 by Boys & Girls Clubs of America (BGCA) ...
... , , PITTSBURGH, Sept. 16 Mylan ... privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative ... the President,s Emergency Plan for AIDS Relief (PEPFAR) for its ... Fumarate Tablets, 600 mg/300 mg/300 mg. , , ...
... , , , ... business of beauty and there was nothing more beautiful at the ... donated by designers such as Giorgio Armani, Tadashi and Luca Luca. ... and even created a Limited Edition Clarisonic just for the occasion. ...
Cached Medicine News:Health News:Video: Members of Congress Receive Legislative Awards From National Amputee Organizations 2Health News:Video: Members of Congress Receive Legislative Awards From National Amputee Organizations 3Health News:Free Screenings During Prostate Cancer Awareness Week 2Health News:Free Screenings During Prostate Cancer Awareness Week 3Health News:Affinion Security Center Launches Benefits to Help Detect and Resolve Medical Identity Theft 2Health News:Affinion Security Center Launches Benefits to Help Detect and Resolve Medical Identity Theft 3Health News:Video: Teen Girls Less Active, but Triple Play Program Bucks Trend 2Health News:Video: Teen Girls Less Active, but Triple Play Program Bucks Trend 3Health News:Video: Teen Girls Less Active, but Triple Play Program Bucks Trend 4Health News:Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets 2Health News:Brooke Burke Debuts Limited Edition 'Couture' Clarisonic on Ultimate Style Stage: The SGK Pink Dress Runway at New York Fashion Week 2Health News:Brooke Burke Debuts Limited Edition 'Couture' Clarisonic on Ultimate Style Stage: The SGK Pink Dress Runway at New York Fashion Week 3
(Date:12/19/2014)... 2014  Sage Analytics ( www.sageanalytics.com ), the ... the testing of marijuana potency and moisture content, ... Profiler, the industry,s first product suite capable of ... portable unit. Designed from the ground ... cannabis industry, the Luminary™ Profiler utilizes specially purposed ...
(Date:12/19/2014)... Ky. , Dec. 18, 2014 Baptist Health ... States to receive full Atrial Fibrillation with Electrophysiology ... Care (SCPC). Atrial fibrillation is the most common ... that in some cases can lead to stroke and possible ... United States have atrial fibrillation and the numbers ...
(Date:12/19/2014)... robust development with the growth pace keeping at 20%-30% in ... the size of China separating membrane ... to 16.3%. It is projected that China ... around 20% in the upcoming years and that the figure ... An integrated membrane industrial system has taken shape in ...
Breaking Medicine Technology:Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3
... shows that loss of Arf gene in presence ... growth-enhancing environment of the bone,marrow, helping cells develop ... Tenn., Aug. 29 Results of a study,by ... strong,evidence for why the drug imatinib (Gleevec(TM)), which ...
... First-In-Human Study to Cancer Patients, SALT LAKE ... that its first-in-humans Phase 1 study of PRLX ... evaluate the safety,pharmacokinetic and pharmacodynamic properties of PRLX ... include TGen Clinical Research at,Scottsdale Healthcare in Scottsdale, ...
Cached Medicine Technology:St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia 2Prolexys Pharmaceuticals Initiates Phase 1 Study 2
Bruns (Volkmann) bone curette, with Novotex plastic handle (autoclavable in autoclave up to 143C by 3 bar), 9, oval....
15" overall length, 9" handle....
9.5" overall length, 4.5" handle....
...
Medicine Products: